Medisys – results

Medisys, the medical product manufacturer, increased pre-tax losses in the six months to 31 March as it invested further in its new safety syringe. It hopes to begin production this year pending approval from the US Food and Drug Administration.

Medisys, the medical product manufacturer, increased pre-tax losses in the six months to 31 March as it invested further in its new safety syringe. It hopes to begin production this year pending approval from the US Food and Drug Administration.